AML Tx for Fit Patients

CE

Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Released: January 10, 2022

Expiration: January 09, 2023

Activity

Progress
1
Course Completed

In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:

  • Induction chemotherapy and consolidation therapy
  • Use of gemtuzumab ozogamicin
  • Management of sinusoidal obstruction syndrome  
  • Nursing considerations for younger, fit patients with AML